Compare Organon Pharma Indonesia Tbk. (SCPI) vs Semacom Integrated Tbk. (SEMA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Semacom Integrated Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Semacom Integrated Tbk. trades at Rp146 (market cap 177.84B, 83.16M 24h volume). The key difference: Semacom Integrated Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| SCPI | SEMA | |
|---|---|---|
Market Cap | 104.4B | 177.84B |
Volume | — | 83.16M |
Lot | — | 831.61K |
Turnover | — | 12.19B |
Average Price | — | 146.55 |
Value | — | 12.19B |
Indicative Equilibrium Price | — | 146 |
Indicative Equilibrium Volume | — | 8.23K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Semacom Integrated Tbk.
PT Semacom Integrated Tbk (the Company) was established in the Republic of Indonesia on October 01, 2009 based on Notarial deed No. 5 of H. Dana Sasmita, S.H, Notary in Jakarta The Company begin opertions commercial activities since 2009.
Read more on SEMA →
